Avid Bioservices Future Growth
Future criteria checks 1/6
Avid Bioservices is forecast to grow earnings and revenue by 139% and 20% per annum respectively while EPS is expected to grow by 139.1% per annum.
Key information
139.0%
Earnings growth rate
139.1%
EPS growth rate
| Biotechs earnings growth | 42.4% |
| Revenue growth rate | 20.0% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 07 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 4/30/2027 | 237 | 9 | 21 | N/A | 2 |
| 4/30/2026 | 198 | -4 | 8 | 18 | 5 |
| 4/30/2025 | 140 | -19 | -5 | -2 | 5 |
| 7/31/2024 | 142 | -144 | -11 | 8 | N/A |
| 4/30/2024 | 140 | -141 | -21 | 11 | N/A |
| 1/31/2024 | 137 | -18 | -38 | 13 | N/A |
| 10/31/2023 | 141 | -12 | -56 | 2 | N/A |
| 7/31/2023 | 150 | -3 | -93 | -8 | N/A |
| 4/30/2023 | 149 | 0 | -91 | -13 | N/A |
| 1/31/2023 | 141 | 116 | -92 | -15 | N/A |
| 10/31/2022 | 134 | 119 | -89 | -3 | N/A |
| 7/31/2022 | 126 | 123 | -48 | 11 | N/A |
| 4/30/2022 | 120 | 128 | -47 | 9 | N/A |
| 1/31/2022 | 116 | 10 | -9 | 27 | N/A |
| 10/31/2021 | 106 | 9 | 8 | 27 | N/A |
| 7/31/2021 | 101 | 6 | 13 | 27 | N/A |
| 4/30/2021 | 96 | 3 | 21 | 31 | N/A |
| 1/31/2021 | 81 | 0 | 10 | 16 | N/A |
| 10/31/2020 | 73 | -5 | 5 | 11 | N/A |
| 7/31/2020 | 70 | -7 | 2 | 6 | N/A |
| 4/30/2020 | 60 | -15 | 2 | 6 | N/A |
| 1/31/2020 | 64 | -10 | 5 | 8 | N/A |
| 10/31/2019 | 64 | -9 | 4 | 6 | N/A |
| 7/31/2019 | 56 | -11 | -8 | -7 | N/A |
| 4/30/2019 | 54 | -10 | -13 | -12 | N/A |
| 1/31/2019 | 43 | -16 | -18 | -15 | N/A |
| 10/31/2018 | 37 | -24 | -23 | -21 | N/A |
| 7/31/2018 | 39 | -30 | -25 | -21 | N/A |
| 4/30/2018 | 54 | -25 | N/A | -26 | N/A |
| 1/31/2018 | 65 | -17 | N/A | -40 | N/A |
| 10/31/2017 | 69 | 6 | N/A | -42 | N/A |
| 7/31/2017 | 79 | 11 | N/A | -34 | N/A |
| 4/30/2017 | 58 | -3 | N/A | -39 | N/A |
| 1/31/2017 | 59 | -17 | N/A | -33 | N/A |
| 10/31/2016 | 54 | -48 | N/A | -30 | N/A |
| 7/31/2016 | 41 | -57 | N/A | -40 | N/A |
| 4/30/2016 | 44 | -1 | N/A | -40 | N/A |
| 1/31/2016 | 35 | -60 | N/A | -36 | N/A |
| 10/31/2015 | 34 | -56 | N/A | -38 | N/A |
| 7/31/2015 | 31 | -55 | N/A | -41 | N/A |
| 4/30/2015 | 27 | -54 | N/A | -36 | N/A |
| 1/31/2015 | 24 | -51 | N/A | -40 | N/A |
| 10/31/2014 | 22 | -47 | N/A | -39 | N/A |
| 7/31/2014 | 23 | -42 | N/A | -33 | N/A |
| 4/30/2014 | 22 | -36 | N/A | -28 | N/A |
| 1/31/2014 | 20 | -34 | N/A | -26 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: TEHP is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: TEHP is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: TEHP is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: TEHP's revenue (20% per year) is forecast to grow faster than the German market (5.6% per year).
High Growth Revenue: TEHP's revenue (20% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if TEHP's Return on Equity is forecast to be high in 3 years time